Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EMERGENT BIOSOLUTIONS INC.

(EBS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 3 0202 7854 7492 378--
Entreprise Value (EV)1 3 7023 4285 0022 7492 1242 378
P/E ratio 48,6x51,9x15,8x10,4x14,3x16,0x
Yield ------
Capitalization / Revenue 3,86x2,52x3,05x1,41x1,65x1,88x
EV / Revenue 4,73x3,10x3,22x1,63x1,47x1,88x
EV / EBITDA 18,6x12,3x7,94x5,43x5,20x-
Price to Book 3,00x2,55x3,29x1,34x1,18x-
Nbr of stocks (in thousands) 50 94551 62452 99953 799--
Reference price (USD) 59,354,089,644,244,244,2
Announcement Date 02/21/201902/20/202002/18/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 7821 1061 5551 6891 4441 265
EBITDA1 199280630506409-
Operating profit (EBIT)1 89,8114434341287240
Operating Margin 11,5%10,3%27,9%20,2%19,9%19,0%
Pre-Tax Profit (EBT)1 81,577,4407304257209
Net income1 62,754,5305230174157
Net margin 8,01%4,93%19,6%13,6%12,0%12,4%
EPS2 1,221,045,674,263,102,76
Dividend per Share ------
Announcement Date 02/21/201902/20/202002/18/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 343398329620302340
EBITDA1 12449,5-3,30332--
Operating profit (EBIT)1 95,414,5-34,726689,590,3
Operating Margin 27,8%3,65%-10,5%42,9%29,6%26,6%
Pre-Tax Profit (EBT)1 85,27,20-45,525779,480,2
Net income1 69,74,60-32,717059,360,0
Net margin 20,3%1,16%-9,94%27,4%19,6%17,6%
EPS2 1,280,09-0,613,470,260,67
Dividend per Share ------
Announcement Date 04/29/202107/29/202111/04/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 682643254371--
Net Cash position1 ----254-
Leverage (Debt / EBITDA) 3,43x2,30x0,40x0,73x-0,62x-
Free Cash Flow1 -30,3101395-276438265
ROE (Net Profit / Equities) 12,4%14,5%33,4%21,1%7,84%-
Shareholders' equity1 5043769121 0912 220-
ROA (Net Profit / Asset) 7,25%6,68%16,3%11,4%4,78%-
Assets1 8658161 8752 0113 637-
Book Value Per Share2 19,721,127,333,037,4-
Cash Flow per Share ------
Capex1 72,186,914117210080,0
Capex / Sales 9,22%7,86%9,07%10,2%6,92%6,32%
Announcement Date 02/21/201902/20/202002/18/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 2 378 438 935
Net sales (USD) 1 555 400 000
Number of employees 2 200
Sales / Employee (USD) 707 000
Free-Float 88,6%
Free-Float capitalization (USD) 2 106 661 219
Avg. Exchange 20 sessions (USD) 55 120 573
Average Daily Capital Traded 2,32%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA